Skip to content

Clinical Course of Korean Crohn's Disease Cohort

Clinical Course of Crohn's Disease: a Prospective Multicenter Long-term Follow-up Study in Korea

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01554007
Enrollment
2000
Registered
2012-03-14
Start date
2012-12-31
Completion date
2019-12-31
Last updated
2016-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Keywords

Crohn's disease

Brief summary

In the past decade, the incidence and prevalence of CD (Crohn's disease) has continued to increase in Korea. Previous studies have indicated that Asian IBD (inflammatory bowel disease) patients differ from those of Western patients with regard to the genetic susceptibility and some clinical features. However, the available published data from retrospective studies in Korea were largely incomplete. The investigators aim of the study is a set-up of Korean cohort for CD, and thereby to assess the clinical course of Korean CD patients through a prospective multicenter long-term follow-up study. Secondary aims of this study are as follows: (1) to evaluate the efficacy, tolerability, and predictors to response to anti-TNF therapy for CD, (2) to identify the risk factors for postoperative recurrence on the basis of information obtained at initial diagnosis, and (3) to evaluate genotype-phenotype correlation.

Detailed description

From 2009 to 2018, new cases of CD diagnosed will be recruited. Participants for this study will be enrolled from 33 academic teaching hospitals or colorectal specialized hospitals across Korea. Medical records will be used to register demographic data, disease phenotype, the use of medication, flare-ups, surgery, hospitalizations, and mortality. Whole blood will be collected to central biobank with extraction of DNA ans seroum. The Montreal classification of Crohn's disease and the Crohn's disease activity index (CDAI) will be used to describe disease location, behavior and severity. F/U data will be analyzed using Kaplan-Meier analysis with log rank test and Cox regression analysis. An electronic database will be established in use of processing data.

Interventions

No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.

Sponsors

Asan Medical Center
CollaboratorOTHER
Hanyang University
CollaboratorOTHER
Seoul National University
CollaboratorOTHER
Severance Hospital
CollaboratorOTHER
Samsung Medical Center
CollaboratorOTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
CollaboratorOTHER
Kyung Hee University Hospital at Gangdong
CollaboratorOTHER
Kangbuk Samsung Hospital
CollaboratorOTHER
Konyang University Hospital
CollaboratorOTHER
Korea University Anam Hospital
CollaboratorOTHER
Korea University
CollaboratorOTHER
Eulji General Hospital
CollaboratorOTHER
Eulji University
CollaboratorOTHER
SMG-SNU Boramae Medical Center
CollaboratorOTHER
Pusan National University Hospital
CollaboratorOTHER
Inje University
CollaboratorOTHER
Soonchunhyang University Hospital
CollaboratorOTHER
Songdo hospital
CollaboratorUNKNOWN
Yeungnam University Hospital
CollaboratorOTHER
Wonkwang University
CollaboratorOTHER
Wonju Severance Christian Hospital
CollaboratorOTHER
Ewha Womans University
CollaboratorOTHER
Chonnam National University Hospital
CollaboratorOTHER
Jeju National University Hospital
CollaboratorOTHER
Chuncheon Sacred Heart Hospital
CollaboratorOTHER
Hangang Sacred Heart Hospital
CollaboratorOTHER
Dongtan Sacred Heart Hospital
CollaboratorOTHER
Chungbuk National University Hospital
CollaboratorOTHER
The Catholic University of Korea
CollaboratorOTHER
Kyunghee University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over the age of 16 * Informed consent * Patients who had a definitive diagnosis of Crohn's disease (documented by the standard clinical, radiographic, endoscopic, and histopathologic criteria) * be capable of understanding the study and replying to the questionnaires

Exclusion criteria

* Any condition which, in the opinion of the Investigator, places the patient at unacceptable risk if he/she were to participate in the study

Design outcomes

Primary

MeasureTime frame
To explore natural course of Crohn's disease and to identify prognostic factors for poor disease outcome in Korean patients with Crohn's disease10 years

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026